Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying the right ones can be challenging due to inherent volatility and risks [1] Group 1: Growth Stock Identification - The Zacks Growth Style Score system aids in identifying promising growth stocks by analyzing real growth prospects beyond traditional metrics [2] - Adobe Systems (ADBE) is currently highlighted as a recommended growth stock, possessing a favorable Growth Score and a top Zacks Rank [2] Group 2: Earnings Growth - Earnings growth is crucial for growth investors, with double-digit growth being highly desirable as it indicates strong future prospects [3] - Adobe's historical EPS growth rate stands at 14%, with projected EPS growth of 11.8% this year, surpassing the industry average of 11.5% [4] Group 3: Cash Flow Growth - Higher-than-average cash flow growth is vital for growth-oriented companies, enabling expansion without reliance on external funding [5] - Adobe's year-over-year cash flow growth is currently at 11.9%, exceeding the industry average of 9.4% [5] - The company's annualized cash flow growth rate over the past 3-5 years is 13.6%, compared to the industry average of 10.5% [6] Group 4: Earnings Estimate Revisions - Positive trends in earnings estimate revisions are significant, as they correlate strongly with near-term stock price movements [7] - Adobe has experienced upward revisions in current-year earnings estimates, with a 2.1% increase in the Zacks Consensus Estimate over the past month [7] Group 5: Overall Assessment - Adobe has achieved a Growth Score of A and a Zacks Rank of 2, indicating positive earnings estimate revisions and strong growth potential [8] - This combination positions Adobe as a potential outperformer and a solid choice for growth investors [9]

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying strong candidates involves navigating inherent risks and volatility [1] Group 1: Company Overview - Arcosa (ACA) is highlighted as a recommended growth stock with a favorable Growth Score and a top Zacks Rank [2] - The company specializes in infrastructure-related products and services, making it a relevant choice for growth investors [3] Group 2: Earnings Growth - Historical EPS growth for Arcosa stands at 8.6%, but projected EPS growth for this year is significantly higher at 26.7%, outperforming the industry average of 6.6% [5] Group 3: Cash Flow Growth - Arcosa's year-over-year cash flow growth is currently at 8%, exceeding the industry average of 3.1% [6] - The company's annualized cash flow growth rate over the past 3-5 years is 11.3%, compared to the industry average of 10% [7] Group 4: Earnings Estimate Revisions - There has been a positive trend in earnings estimate revisions for Arcosa, with the Zacks Consensus Estimate for the current year increasing by 1.1% over the past month [8] Group 5: Investment Potential - Arcosa holds a Zacks Rank of 2 (Buy) and a Growth Score of B, indicating its potential as a solid choice for growth investors [9][10]

Core Viewpoint - Investors are increasingly seeking growth stocks that demonstrate above-average growth potential, with Intuit (INTU) identified as a strong candidate due to its favorable growth metrics and Zacks Rank [2][8]. Group 1: Earnings Growth - Intuit has a historical EPS growth rate of 15.4%, with projected EPS growth of 18.4% for the current year, significantly outperforming the industry average of 11.8% [4]. Group 2: Cash Flow Growth - The year-over-year cash flow growth for Intuit stands at 15.7%, exceeding the industry average of 9.4%. The company's annualized cash flow growth rate over the past 3-5 years is 19.2%, compared to the industry average of 10.5% [5][6]. Group 3: Earnings Estimate Revisions - There has been a positive trend in earnings estimate revisions for Intuit, with the Zacks Consensus Estimate for the current year increasing by 4.1% over the past month, contributing to its Zacks Rank 1 status [7][8].

Group 1 - The management team has effectively encouraged customers to opt for recurring purchases [1]

Not many companies that have been around since the late 1800s can claim that they're growth companies. But Eli Lilly (LLY 0.82%) can. However, even growth stocks with long and impressive track records can see their share prices take a breather.Eli Lilly's stock is down about 6.4% over the last year through June 12. Some may worry about such a drop, but I don't believe that's a warning sign for investors. Rather, investors should think of this dip as a buying opportunity. Eli Lilly is gaining in weight lossE ...

Core Viewpoint - Five Below has demonstrated significant growth, with a 19.5% year-over-year revenue increase, positioning itself as a strong investment opportunity despite its competitive retail environment [5][6]. Company Performance - Five Below's revenue reached $970.5 million in Q1 2025, surpassing Wall Street estimates, and same-store sales increased by 7.1% [5]. - The company has expanded its store count from 385 in Q1 2015 to 1,826 as of the latest fiscal quarter, with a long-term goal of reaching 3,500 stores [6]. Market Environment - The retail sector is highly competitive, characterized by low profit margins and changing consumer preferences, which can deter investors [4]. - Five Below's performance is influenced by the broader economic environment, with retailers generally thriving when the economy is strong [8]. Macro Factors - The company is currently managing the impact of tariffs, having reduced goods sourced from China by 10% [10]. - There is concern regarding a potential U.S. recession, which could lead to decreased consumer discretionary spending and negatively affect demand for Five Below's products [11]. Valuation Considerations - The stock's price-to-earnings ratio has increased from 12.2 to 25.8, indicating that it is no longer considered a bargain [12]. - Despite the higher valuation, growth-oriented investors may still find Five Below an attractive addition to their portfolios [13].

Core Viewpoint - Investors are increasingly seeking growth stocks that demonstrate above-average growth potential, with DXP Enterprises identified as a strong candidate due to its favorable growth metrics and Zacks Rank [1][2]. Group 1: Earnings Growth - DXP Enterprises has a historical EPS growth rate of 60.2%, with projected EPS growth of 17.5% for the current year, significantly outperforming the industry average of 5% [5]. Group 2: Cash Flow Growth - The company exhibits a year-over-year cash flow growth of 6.5%, surpassing the industry average of 1.6%. Additionally, its annualized cash flow growth rate over the past 3-5 years stands at 12.3%, compared to the industry average of 9% [6][7]. Group 3: Earnings Estimate Revisions - There have been upward revisions in current-year earnings estimates for DXP Enterprises, with the Zacks Consensus Estimate increasing by 0.4% over the past month, indicating positive momentum [9]. Group 4: Overall Positioning - DXP Enterprises holds a Growth Score of B and a Zacks Rank of 2, positioning it favorably for potential outperformance in the growth stock category [10][11].

Core Viewpoint - Growth investors are focused on stocks with above-average financial growth, but identifying stocks that can fulfill their growth potential is challenging [1] Group 1: Company Overview - HealthEquity (HQY) is currently recommended as a growth stock due to its favorable Growth Score and top Zacks Rank [2] - The company has a historical EPS growth rate of 19.1%, with projected EPS growth of 15.8% this year, significantly higher than the industry average of 7.7% [5] Group 2: Financial Metrics - HealthEquity's year-over-year cash flow growth is 25.9%, outperforming the industry average of -1.5% [6] - The company's annualized cash flow growth rate over the past 3-5 years is 19.3%, compared to the industry average of 8% [7] Group 3: Earnings Estimates - There has been a positive trend in earnings estimate revisions for HealthEquity, with the Zacks Consensus Estimate for the current year increasing by 6.5% over the past month [8] - HealthEquity has earned a Growth Score of B and carries a Zacks Rank 2 due to positive earnings estimate revisions, indicating it is a potential outperformer for growth investors [10]

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying strong candidates can be challenging due to inherent risks and volatility [1] Group 1: Company Overview - Intuit (INTU) is highlighted as a promising growth stock, supported by a favorable Growth Score and a top Zacks Rank [2][9] Group 2: Earnings Growth - Intuit's historical EPS growth rate stands at 15.4%, with projected EPS growth of 18% this year, significantly surpassing the industry average of 10.9% [4][3] Group 3: Cash Flow Growth - The year-over-year cash flow growth for Intuit is currently 15.7%, exceeding the industry average of 9.9% [5] - Over the past 3-5 years, Intuit's annualized cash flow growth rate has been 19.2%, compared to the industry average of 10.3% [6] Group 4: Earnings Estimate Revisions - There has been a positive trend in earnings estimate revisions for Intuit, with the Zacks Consensus Estimate for the current year increasing by 4.1% over the past month [7][9]

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying strong candidates can be challenging due to inherent volatility and risks [1] Group 1: Company Overview - Palomar (PLMR) is currently highlighted as a promising growth stock, supported by a favorable Growth Score and a top Zacks Rank [2] - The historical EPS growth rate for Palomar is 54%, with projected EPS growth of 36.1% this year, significantly outperforming the industry average of 3.4% [4] Group 2: Financial Metrics - Cash flow growth is crucial for growth-oriented companies, and Palomar's year-over-year cash flow growth stands at 45.1%, compared to the industry average of 15% [5] - The annualized cash flow growth rate for Palomar over the past 3-5 years is 25.5%, while the industry average is 11.5% [6] Group 3: Earnings Estimates - Positive trends in earnings estimate revisions are indicative of potential stock price movements, and Palomar's current-year earnings estimates have increased by 3.1% over the past month [8] - Palomar has achieved a Zacks Rank of 2 due to favorable earnings estimate revisions and has earned a Growth Score of B based on various metrics [10]